- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypercholesterolaemia
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Evolocumab – July 2019
Evolocumab: Injection 420 mg in 3.5 mL single use pre-filled cartridge, Injection 140 mg in 1 mL single use pre-filled pen; Repatha®
Last updated
15 November 2019